Progressive external ophthalmoplegia in southwestern Finland: A clinical and genetic study

Neuroepidemiology

Volumn 38, Issue 2, 2012, Pages 114-119

  Martikainen, Mika H ^a   Hinttala, Reetta ^b,c   Röyttä, Matias ^a   Jääskeläinen, Satu ^a   Wendelin Saarenhovi, Maria ^a   Parkkola, Riitta ^a   Majamaa, Kari ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Epidemiology of mitochondrial disease; Mitochondrial DNA deletions; POLG1; Progressive external ophthalmoplegia

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; DNA SEQUENCE; ELECTROMYOGRAPHY; ELECTRONEUROMYOGRAPHY; EXTRAOCULAR MUSCLE; FEMALE; FINLAND; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITOCHONDRIAL DNA DISORDER; MUSCLE BIOPSY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; REGISTER;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; ADULT; AGED; AGED, 80 AND OVER; DNA HELICASES; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; POINT MUTATION; PREVALENCE; SEQUENCE DELETION;

EID: 84857488022     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000336112     Document Type: Article

References (31)

1. Van Goethem G, Martin JJ, Van Broeckhoven C: Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: Unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Med 2003; 3: 129-146.
2. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-719.
3. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, Rowland LP: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38: 1339-1346.
4. Holt IJ, Harding AE, Cooper JM, Schapira AH, Toscano A, Clark JB, Morgan-Hughes JA: Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989; 26: 699-708.
5. Lauber J, Marsac C, Kadenbach B, Seibel P: Mutations in mitochondrial tRNA genes: A frequent cause of neuromuscular diseases. Nucleic Acids Res 1991; 19: 1393-1397.
6. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, Schon EA, Bonilla E, DiMauro S: Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993; 3: 43-50.
7. Raffelsberger T, Rossmanith W, Thaller-Antlanger H, Bittner RE: CPEO associated with a single nucleotide deletion in the mitochondrial tRNA Tyr gene. Neurology 2001; 57: 2298-2301.
8. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S: An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-311.
9. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S: Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996; 46: 1329-1334.
10. Suomalainen A, Kaukonen J, Amati P, Timonen R, Haltia M, Weissenbach J, Zeviani M, Somer H, Peltonen L: An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995; 9: 146-151.
11. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, Larsson C: Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001; 28: 223-231.
12. Kaukonen J, Juselius JK, Tiranti V, Kyttälä A, Zeviani M, Comi GP, Keränen S, Peltonen L, Suomalainen A: Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000; 289: 782-785.
13. Van Goethem G, Dermaut B, Löfgren A, Martin JJ, Van Broeckhoven C: Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001; 28: 211-212.
14. Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S, Papadimitriou A, Spelbrink H, Silvestri L, Casari G, Comi GP, Zeviani M: Mutations of mitochondrial DNA polymerase A are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002; 52: 211-219.
15. Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, Nightingale S, Turnbull DM, Copeland WC, Chinnery PF: Mutant POLG2 disrupts DNA polymerase subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006; 78: 1026-1034.
16. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, Griffiths PG, Ahlqvist K, Suomalainen A, Reynier P, Mc-Farland R, Turnbull DM, Chinnery PF, Taylor RW: Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: A novel disorder of mtDNA maintenance. Brain 2008; 131: 329-337.
17. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiére A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Martín MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, Carelli V: OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008; 131: 338-351.
18. Stewart JD, Hudson G, Yu-Wai-Man P, Blakely EL, He L, Horvath R, Maddison P, Wright A, Griffiths PG, Turnbull DM, Taylor RW, Chinnery PF: OPA1 in multiple mitochondrial DNA deletion disorders. Neurology 2008; 71: 1829-1831.
19. Tyynismaa H, Ylikallio E, Patel M, Molnar MJ, Haller RG, Suomalainen S: A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am J Hum Genet 2009; 85: 290-295.
20. Fratter C, Raman P, Alston CL, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Hanna MG, Poulton J, Brierley C, Staunton TG, Turnpenny PD, Schaefer AM, Chinnery PF, Horvath R, Turnbull DM, Gorman GS, Taylor RW: RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. Neurology 2011; 76: 2032-2034.
21. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE: Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population. Am J Hum Genet 1998; 63: 447-454.
22. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamäki M, Goethem GV, Löfgren A, Hackman P, Paetau A, Kaakkola S, Majamaa K, Varilo T, Udd B, Kääriäinen H, Bindoff LA, Suomalainen A: Mitochondrial DNA polymerase W748S mutation: A common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005; 77: 430-441.
23. Kalton G, Anderson DW: Sampling rare populations. J R Stat Soc A 1986; 149: 65-82.
24. Virgilio R, Ronchi D, Hadjigeorgiou GM, Bordoni A, Saladino F, Moggio M, Adobbati L, Kafetsouli D, Tsironi E, Previtali S, Papadimitriou A, Bresolin N, Comi GP: Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia. J Neurol 2008; 255: 1384-1391.
25. Agostino A, Valletta L, Chinnery PF, Ferrari G, Carrara F, Taylor RW, Schaefer AM, Turnbull DM, Tiranti V, Zeviani M: Mutations of ANT1 , Twinkle , and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003; 60: 1354-1356.
26. Hudson G, Deschauer M, Taylor RW, Hanna MG, Fialho D, Schaefer AM, He LP, Blakely E, Turnbull DM, Chinnery PF: POLG1 , C10ORF2 , and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Neurology 2006; 66: 1439-1441.
27. Remes AM, Majamaa-Voltti K, Kärppä M, Moilanen JS, Uimonen S, Helander H, Rusanen H, Salmela PI, Sorri M, Hassinen IE, Majamaa K: Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology 2005; 64: 976-981.
28. Zeviani M, Amati P, Bresolin N, Antozzi C, Piccolo G, Toscano A, DiDonato S: Rapid detection of the A-G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1991; 48: 203-211.
29. Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Gutiérres Ríos P, Hirano M, Copeland WC, DiMauro S: Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1 Arch Neurol 2008; 65: 125-131.
30. Mancuso M, Filosto M, Oh SJ, DiMauro S: A novel polymerase mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism. Arch Neurol 2004; 61: 1777-1779.
31. Martikainen MH, Hinttala R, Majamaa K: Novel POLG1 mutations in a patient with adult-onset progressive external ophthalmoplegia and encephalopathy. BMJ Case Reports 2010. DOI: 10.1136/bcr.01.2010.2604.